CAS: 56309-56-9; 2-Isopropylphenylisocyanate

该化合物是一种多用途有机化合物,主要用作尿素,氨基甲酸盐和其他异氰酸盐衍生产品的合成中间体,其反应性异氰酸酯组能够有效地融入聚合物,农用化学品和药品,提供精确的功能化.异丙基替代成分可增强消毒和电子特性,影响目标应用的回动性和稳定性.该化合物因其在生产高性能涂层,粘合剂和特殊化学品方面的作用而特别受到重视,在这些化学品中,受控的回性性和结构特性至关重要.适当的处理由于其湿度敏感性和潜在的健康危害,至关重要.在受控制的条件下,工业和研究用途是合适的.

结构式图片

相似化合物

56309-60-5 28178-42-9 614-68-6

欧盟法规

ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

CAS号851199-82-1 2-isopropylphen... | CAS号917-61-3 氰酸钠 | CAS号75-44-5 光气 | CAS号643-28-7 2-异丙基苯胺 | CAS号88-69-7 2-异丙基苯酚 | CAS号32315-10-9 三光气

合成工艺路线路线简述

    📜异丙苯酚置于tris-(Dibenzylideneacetone)Dipalladium(0),2-二叔丁基膦-2',4',6'-三异丙基-3,6-二甲氧基-1,1'-联苯,三(3,6-二氧杂庚基)胺,三乙胺体系中,用 二氯甲烷,甲苯 作为反应溶剂,化学反应 30.0H,反应生成 2-异丙基苯异氰酸酯
    参考文献:钯催化合成氨基甲酸芳基酯
    标题:钯催化合成氨基甲酸芳基酯
    摘要:通过将醇引入钯催化的 Arx (X = Cl,Otf) 与氰酸钠的交叉偶联反应中,实现了芳基氨基甲酸酯的有效合成.在此转化中使用芳基三氟甲磺酸酯作为亲电组分允许扩大用于直接合成芳基异氰酸酯的底物范围.该方法提供了对主要氨基甲酸酯保护基团,S-硫代氨基甲酸酯和聚氨酯材料的二异氰酸酯前体的直接访问.
    DOI:10.1021/ol400369N

    海关参考信息

    专利信息


    专利号:US-2005192265-A1
    优先权日:2003-03-20
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-6906056-B2
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    权利人:LILLY CO ELI
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-2004106598-A1
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting Beta-amyloid peptide release and/or its synthesis by use of such compounds

    专利号:US-2005192269-A1
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

    专利号:US-2005267150-A1
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

    专利号:US-6569851-B1
    优先权日:1998-06-22
    标 题 :Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Aubert, C.; Malacria, M.; Ollivier, C., Science of Synthesis: Stereoselective Synthesis, (2011) 3, 199.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知